All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
The lym Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the lym Hub cannot guarantee the accuracy of translated content. The lym and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lymphoma & CLL Hub is an independent medical education platform, sponsored by AbbVie, BeOne Medicines, Johnson & Johnson, Roche, and Sobi, and supported through educational grants from Bristol Myers Squibb, Incyte, Lilly, and Pfizer. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View lym content recommended for you
Mantle cell lymphomas
Mantle cell lymphoma (MCL) is characterized by the chromosomal translocation t(11;14)(q13-3; q32-33), resulting in over-expression of the cell cycle protein, cyclin D1. MCL was only recognized as a separate entity in the 1990s. Novel targeted therapies have been approved for the treatment of MCL, however, many patients relapse and have a poor prognosis.
Filter by content:
All Subtypes
- Activated B-cell-like
- Burkitt lymphoma
- Diffuse large B-cell lymphoma
- Double hit lymphoma
- Epstein – Barr virus-positive diffuse large B-cell lymphoma
- Germinal center B-cell-like
- Gray zone lymphoma
- High-grade B-cell lymphoma
- Intravascular large B-cell lymphoma
- Large B-cell lymphoma
- Large B-cell lymphoma with IRF4 rearrangement
- Primary CNS Lymphoma
- Primary DLBCL of the central nervous system
- Primary mediastinal large B-cell lymphoma
- T-cell/histiocyte-rich large B-cell lymphoma
- Transformed follicular lymphoma
- Anaplastic large cell lymphoma
- Angioimmunoblastic T-cell lymphoma
- Breast implant-associated anaplastic large cell lymphoma
- Cutaneous T-cell lymphoma
- Enteropathy-associated T-cell lymphoma
- Epstein – Barr virus-positive T-cell lymphoma
- Epstein – Barr virus-positive T-cell lymphoma of childhood
- Extranodal NK/T-cell lymphoma
- Follicular T-cell lymphoma
- Hepatosplenic T-cell lymphoma
- Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract
- Monomorphic epitheliotropic intestinal T-cell lymphoma
- Mycosis fungoides
- Peripheral T-cell lymphoma
- Sézary syndrome
- T-cell large granular lymphocytic leukemia
- T-cell prolymphocytic leukemia
- T/NK-cell leukemia